Oppenheimer


Top Analyst Reiterates Positive Stance on Microsoft Corporation (MSFT) as Street Cheers Earnings

Microsoft Corporation (NASDAQ:MSFT) shares are up nearly 5% today, after the software giant blew away expectations for its first fiscal-quarter earnings, posting revenue …

Oppenheimer Cautious on Opko Health Inc. (OPK) Following Non-Coverage Decision from Palmetto

Opko Health Inc. (NASDAQ:OPK) shares tumbled 5% after the Palmetto GBA Medicare Administrative Contractor (MAC) issued a final non-coverage decision for 4Kscore, calling …

Wall Street’s Top Analyst Cautious on General Electric Company (GE) Ahead of FQ3:16 Results

Oppenheimer top analyst Christopher Glynn delves into General Electric Company (NYSE:GE) ahead of the company’s third-quarter print to be posted October 21st, remaining …

Wall Street Analysts Dial Up the Price Target on Apple Inc. (AAPL), Drop the Rating on Twitter Inc (TWTR)

Analysts offer insights into a tale of two technology giants: Apple Inc. (NASDAQ:AAPL) and Twitter Inc (NYSE:TWTR).

Analysts Dive in on Two Volatile Biotech Stocks: Sarepta Therapeutics Inc (SRPT), Vical Incorporated (VICL)

It has been an explosive twenty-four hours in the biotech-verse, as analysts are prompted to offer insights on Sarepta Therapeutics Inc (NASDAQ:SRPT), with shares shooting …

Oppenheimer Top Analyst Weighs in on Skyworks Solutions Inc (SWKS) Following Meetings with Management

Oppenheimer’s top analyst Rick Schafer was out with a research note on shares of Skyworks Solutions Inc (NASDAQ:SWKS), reiterating an Outperform rating with price target …

Biotech Daily Digest: Sarepta Therapeutics Inc (SRPT), Aerie Pharmaceuticals Inc (AERI)

Biotech stocks are looking to erase their losses over the past month today, as the iShares Nasdaq Biotechnology ETF (IBB) gained nearly 2%. Among the equities in …

Oppenheimer Bullish on Sarepta Therapeutics Inc (SRPT) Following Dr. Farkas’ FDA Departure

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares shot up nearly 13% today in the wake of Dr. Ronald Farkas, arguably the most oppositional team leader …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts